HK1250655A1 - Aqueous pharmaceutical formulation of tapentadol for oral administration - Google Patents

Aqueous pharmaceutical formulation of tapentadol for oral administration

Info

Publication number
HK1250655A1
HK1250655A1 HK18110209.6A HK18110209A HK1250655A1 HK 1250655 A1 HK1250655 A1 HK 1250655A1 HK 18110209 A HK18110209 A HK 18110209A HK 1250655 A1 HK1250655 A1 HK 1250655A1
Authority
HK
Hong Kong
Prior art keywords
tapentadol
oral administration
pharmaceutical formulation
aqueous pharmaceutical
aqueous
Prior art date
Application number
HK18110209.6A
Other languages
Chinese (zh)
Inventor
Ulrich Reinhold
Marc Schiller
Eva Cornelia Wulsten
Sabine Karine Katrien Inghelbrecht
Roger Carolus Augusta Embrechts
Ulrich Feil
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HK1250655A1 publication Critical patent/HK1250655A1/en

Links

HK18110209.6A 2011-03-04 2014-06-24 Aqueous pharmaceutical formulation of tapentadol for oral administration HK1250655A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161449287P 2011-03-04 2011-03-04
EP11003601 2011-05-03

Publications (1)

Publication Number Publication Date
HK1250655A1 true HK1250655A1 (en) 2019-01-11

Family

ID=71452834

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18110209.6A HK1250655A1 (en) 2011-03-04 2014-06-24 Aqueous pharmaceutical formulation of tapentadol for oral administration

Country Status (3)

Country Link
ES (1) ES2796370T3 (en)
HK (1) HK1250655A1 (en)
HU (1) HUE049350T2 (en)

Also Published As

Publication number Publication date
ES2796370T3 (en) 2020-11-26
HUE049350T2 (en) 2020-09-28

Similar Documents

Publication Publication Date Title
IL254854A0 (en) Aqueous pharmaceutical formulation of tapentadol for oral administration
EP2747563A4 (en) Compositions and methods thereof for oral administration of drugs
EP2906202A4 (en) Oral drug delivery formulations
IL228709A0 (en) Unit dose form for oral administration
EP2661273A4 (en) Pharmaceutical compositions of iron for oral administration
HRP20160989T1 (en) Solution for oral administration
HK1199843A1 (en) Oral spray formulations and methods for administration of sildenafil
EP2665471A4 (en) Controlled release oral pharmaceutical dosage forms comprising mgbg
EP2567710A4 (en) Aqueous pharmaceutical system for the administration of drugs to the nails
PL2702060T3 (en) Acid addition salts of risperidone and pharmaceutical compositions thereof
ZA201308905B (en) Nasal pharmaceutical formulation comprising fluticasone
AU2012265231A1 (en) Nasal pharmaceutical formulation
IL227651A0 (en) Pharmaceutical formulation for topical administration comprising b220
PL2714042T3 (en) An analgesic pharmaceutical composition for oral administration
HK1250655A1 (en) Aqueous pharmaceutical formulation of tapentadol for oral administration
HUP0900482A2 (en) Pharmaceutical formulation for oral administration